Example: confidence

European Paediatric Formulation Initiative (EuPFi

European Paediatric Formulation Initiative (EuPFi). The 4th Annual Conference of the EuPFI was held in Prague in September 2012. There were 69 abstracts (including oral presentations poster presentations). The abstracts of those presentations are listed below. Poster Abstract tile Authors Contact details of presenting no. author 2 #2 Minimised tablet sizes: Technical Jessica Soto, Peter feasibility compared to adult s tablet Kuehl, Arnaud Mauler, formulations Gesine Winzenburg, and Sabine Desset-Brethes 3 #3 Development of a pediatric Denis Larrouture, Gilles treatment against sickle cell disease lemagnen, Pascal Millet, crisis Steve Amoussou Guenou, Luc Grislain, and Pascale Gueroult 4 #4 Exploring the acceptability of Karen Mooney, James C. Paediatric microneedle-mediated Mcelnay, and Ryan F. monitoring among children Donnelly 5 #5 Influence of Aqueous Kevin Hughes, Hue Ethylcellulose Coating on the Vuong, Marina Levina, Performance of Hydrophilic Tom Farrell, and Ali Polyethylene Oxide Mini-Matrices Rajabi-Siahboomi Containing a Freely Water Soluble Drug 6 #6 The Influence of Hydrophilic Pore Kevin Hughes, Hue Formers on Metoprolol Succinate Vuong, Marina Levina, Release from Mini-tabs Coated with Tom Farrell, and Ali Aqueous Ethylcellulose Dispersion Raj

Formulating Better Medicines for Children microspheres 35 #35 the impact of the european paediatric regulation on authorised medicines for children – uk

Tags:

  Medicine, Paediatric

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of European Paediatric Formulation Initiative (EuPFi

1 European Paediatric Formulation Initiative (EuPFi). The 4th Annual Conference of the EuPFI was held in Prague in September 2012. There were 69 abstracts (including oral presentations poster presentations). The abstracts of those presentations are listed below. Poster Abstract tile Authors Contact details of presenting no. author 2 #2 Minimised tablet sizes: Technical Jessica Soto, Peter feasibility compared to adult s tablet Kuehl, Arnaud Mauler, formulations Gesine Winzenburg, and Sabine Desset-Brethes 3 #3 Development of a pediatric Denis Larrouture, Gilles treatment against sickle cell disease lemagnen, Pascal Millet, crisis Steve Amoussou Guenou, Luc Grislain, and Pascale Gueroult 4 #4 Exploring the acceptability of Karen Mooney, James C. Paediatric microneedle-mediated Mcelnay, and Ryan F. monitoring among children Donnelly 5 #5 Influence of Aqueous Kevin Hughes, Hue Ethylcellulose Coating on the Vuong, Marina Levina, Performance of Hydrophilic Tom Farrell, and Ali Polyethylene Oxide Mini-Matrices Rajabi-Siahboomi Containing a Freely Water Soluble Drug 6 #6 The Influence of Hydrophilic Pore Kevin Hughes, Hue Formers on Metoprolol Succinate Vuong, Marina Levina, Release from Mini-tabs Coated with Tom Farrell, and Ali Aqueous Ethylcellulose Dispersion Rajabi-Siahboomi 7 #7 chewing-gums as Paediatric oral Rossella Dorati, Barbara dosage form to improve the local Colzani, Ida Genta, treatment of oral candidiasis Tiziana Modena, and Bice Conti 8 #8 The use of Eudragit E for coating Anna Kluk and of Paediatric minitablets with Malgorzata Sznitowska candsartan cilexetil 9 #9 Characteristics of disintegrants Eliza Wolska.

2 Magdalena and viscosity increasing substances Boniecka, and for use in ex tempore prepared on a Malgorzata Sznitowska spoon gels for administration of drugs in children 10 #10 stability study of the pediatricSylva Klovrzov , Zdenka oral solutions with propranolol klubalov , Luk . hydrochloride Zah lka, Ludmila Matysov , and Petr Hor k 11 #11 Development and Evaluation of Sonia Cabana Age Appropriate Pellet Formulations Montenegro, Maria for an antiepileptic drug Bego a Delgado-Charro, and Nikoletta Formulating Better Medicines for Fotaki Children 12 #12 Acceptance of and preference Diana A. Van Riet-Nales, among four oral dosage forms in Barbara J. De Neef, infants and pre-school children Alfred Schobben, J. Ferreira, Toine Egberts, and Catharine Rademaker 13 #13 Delivery of aerosolised Ritchie Sharpe, Mark fluticasone propionate via valved Nagel, Valentina holding chamber with facemask: Avvakoumova, Heather Beware facemask leakage Schneider, Rubina Ali, and Jolyon Mitchell 14 #14 Milk-based formulations: The Georgia Charkoftaki, evaluation of meloxicam gastric Evangelos Balafas, tolerability in rats.

3 Nikolas Kostomitsopoulos, Sofia Tseleni-Balafouta, and Panos Macheras 15 #15 Novel milk-based formulations Georgia Charkoftaki, of nsaids: stability and George Voyiatzis, physicochemical characteristics. Athanasios Chrissanthopoulos, Spyros N. Yannopoulos, Dimitris Fatouros, and Panos Macheras 16 #16 comparison of two sodium Nathalie Guffon, Yves phenylbutyrate granule formulations Kibleur, William Coppalu, C. Tissen, and Joerg Breitkreutz 17 #17 Does small intestinal surface Hannah Katharine area correlate to dose adjustment Batchelor and John calculations used in Paediatric Marriott populations? 18 #18 Targeted Paediatric Hannah Katharine biopharmaceutics knowledge is Batchelor and John essential in critical cases Marriott 19 #19 Dexamethasone soluble tablets Zouaoui Bourezg, for Paediatric use Morgan Vabre, Vincent Grek, and Hatem Fessi 20 #20 Lipid microparticles obtained by Zouaoui Bourezg and spray chilling for Paediatric use Hatem Fessi 21 #21 Prevention of vitamin D Sebastiano Antonio insufficiency in Switzerland: a never- Giovanni Lava, Giacomo ending story Domenico Simonetti, and Mario Giovanni Bianchetti 22 #22 Development of a low price Said Fonseca, liquid oral vehicle for Paediatric use Cristiani Lopes, Jamille A.

4 Felix, Marina G. Medeiros, Livia Aline A. Batista, and Helena Lutescia L. Coelho Formulating Better Medicines for Children 23 #23 In vitro deposition testing of two Antje Below, Deborah commercial dry powder inhalers Bickmann, and Joerg using physical mouth-throat models Breitkreutz and simulated inhalation profiles 24 #24 Excipient screening for Eva Julia Laukamp and individually dosing by the Solid J rg Breitkreutz Dosage Pen 25 #25 Evaluation of a novel Praveen Saligram Pharmaburst based ODT. Formulation for weight-specific dosing of Amoxicillin in children 26 #26 Dissolution Evaluation of John Tillotson Actimask 92M, a Novel, Aqueously- Processed Taste-Masked Acetaminophen 27 #27 Development of anti-tb oral Said G. Fonseca, Maria formulations for children A. A. Josino, Livia Aline A. Batista, Marina Medeiros, Helena Lutescia L. Coelho, and Fernanda N.

5 Raffin 28 #28 EU Pediatric Regulation: do L. Schrier, M. Holmes, A. children really benefit(1)? Mui, J. Van Gerven, and A. Cohen 29 #29 EU Pediatric Regulation: do L. Schrier, A. Mui, M. children really benefit(2)? Holmes, J. Van Gerven, and A. Cohen 30 #30 optimizing the taste-masked Thanh Huong HOANG @univ- Formulation of acetaminophen using THI, Mohamed sodium caseinate and lecithin by LEMDANI, and Marie- experimental design Pierre FLAMENT. 31 #31 Development of Spherical Takahiro Endo, Formulation of candesartan cilexetil Masahiro Goto, Masato for children Takahashi, Hideki Nakajima, Yoichi Ishikawa, Hidefumi Nakamura, and Junichiro Fujimoto 32 #32 Medicines for Children in Japan - Masaaki Habara, New approach to bitter medicines - Hidekazu Ikezaki, Maki Yoneko, Sayaka Murata, and Jun Kojima 33 #33 determining surfactant effect in Peter Mbwiiri Ikamati, residual oil inclusion during the Yvonne Perrie, Roderick development of taste masked B.

6 Walker, and Daniel J. microsphere processing method. Kirby 34 #34 the development of a flow Peter Mbwiiri Ikamati, through dissolution test method for Yvonne Perrie, Roderick the determination of flucloxacillin B. Walker, and Daniel J. release properties of taste masked Kirby Formulating Better Medicines for Children microspheres 35 #35 the impact of the European Sarah K. Branch Paediatric regulation on authorised medicines for children uk experience 36 #36 A questionnaire on factors Maki Yoneko, Nao yoneko- influencing clinical development of Tuschida, Nanako medicines for children in Japan Nagafuchi, Tetsuharu Nagamoto, Michihiro Kitagawa, and Jun Kojima 38 #38 Considerations of children and Lidwien Hanff, M. parents to participate in a pediatric Cavazza, R. Pieters, and Formulation trial C. Zwaan 39 #39 Printing of personalized Natalja Genina, Daniela medicine for Paediatric and geriatric Fors, Petri Ihalainen, use Jouko Peltonen, and Niklas Sandler 40 #40 Taste Assessment of Xolani Dereck Methylxanthines using an Electronic Gondongwe, Duncan Tongue Craig, Paul Flanders, David Wright, and Paul Grassby 41 #41 Electronic taste assessment of Maren Preis, Katharina bilayer orodispersible films Schneider, Jennifer Kukawka, Jens Broscheit, Norbert Roewer, and J rg Breitkreutz 42 #42 Introduction of a new Maren Preis and J rg disintegration test for orodispersible Breitkreutz films 43 #43 Melt granulation as a single-step Carolin Eckert, Miriam manufacturing process of a taste Pein, and J rg masked dosage form containing a Breitkreutz highly soluble API.

7 44 #44 Development of a palatable Maren Preis, Jens midazolam Formulation for Paediatric Broscheit, Norbert use Roewer, and J rg Breitkreutz 45 #45 A new bilastine tablet: E. BEASCOA, L. dispersible for Paediatric use. GONZ LEZ, C. PUMAR, I. Industrial scale-up and stability ORTEGA, H. BLANCO, K. evaluation. SUSTACHA, E. CORTA, A. GONZALO, and LUCERO. Formulating Better Medicines for Children 46 #46 Palatability study of a flavored Marina Garruti low price liquid oral vehicle for Medeiros, Deborah pediatric use among children and Santos Garruti, Patr cia parents Pontes Th , Said Cruz Fonseca, Maria Aparecida Josino, Solange Cecilia Dantas, Cristiani Lopes Oliveira, and Helena Luna Coelho 47 #47 Development of a pediatric Roger C. Embrechts, Formulation for a poorly soluble anti- Urbain Delaet, Guy HIV compound Smans, and Albertina Ari n 48 #48 Exposition of neonates to toxic ALCIDESIO SALES SOUZA pharmaceutical excipients in a NICU JR, SARA CORREA C.

8 In Brasilia-Brazil, a followup study. FIGUEIREDO, RAFAEL. SOUZA SANTOS, DJANILSON BARBOSA. SANTOS, and HELENA L. LUNA COELHO. 49 #49 Characterization of commercially Ana Borges, Cl udia available oral dispersible films (odfs) Silva, Jorge Coelho, and S rgio Sim es 50 #50 Fast disintegrating tablet Stefanie Bold and Peter Formulation forming a viscous pulp Gruber easy to swallow 51 #51 end-user perceptions, Sejal Ranmal, Anne preferences and practices: piloting Cram, and Catherine the children's acceptability of oral Tuleu formulations' (calf) medicines survey 52 #52 actively involving children and Sejal Ranmal, Catherine young people in research lessons Tuleu, and Jennifer learnt from developing and pre- Newman testing the calf survey questionnaires 53 #53 2nd Generation of Mini-Tablet Rolf Eilers Dosing Dispenser - a Simple and Affordable Solution 54 #54 Developing the New Type of Oral Shuji Morimoto Dosage Form for Children: GT (Gel Together).

9 55 #55 Technology of the New Type of Shuji Morimoto Oral Dosage Form for Children: Gel Together (GT ). 56 #56 Age-Appropriate Evaluation and Jennifer C. Duncan, Availability of Enteral Drug Samuel Orubu, Formulations Recommended in Catherine Tuleu, Mark Essential Medicines List for Children A. Turner, and Anthony J. Nunn 57 #57 amlodipine: exploring the Paul mccague, Caoimhe methods to achieve a mg dose. Quinn, Lesley-Ann Formulating Better Medicines for Children mccullough, James mcelnay, and Ryan Donnelly 58 #58 Paediatric extemporaneous Paul mccague, James formulations: a service evaluation in mcelnay, and Ryan the primary care setting Donnelly 59 #59 opinions & experiences of Paul mccague, James community and hospital pharmacists mcelnay, and Ryan on extemporaneous preparation of Donnelly medicines and specials. 60 #60 Extemporaneous compounding Samuel Orubu, Chinyere in Nigeria - A pilot study of a Okwelogu, Tony Nunn, children's unit in a tertiary hospital and Catherine Tuleu 61 #61 Oral priority medicines for Samuel Orubu, Jennifer children: Availability in the United Duncan, Mark A.

10 Turner, Kingdom ( ) and United States Tony Nunn, and ( ) Catherine Tuleu 62 #62 medicine flavour and Daniel Jon Kirby, Carly Formulation preference amongst Tibbins, Claire Callens, school children in the west midlands and John Marriott region of the uk 63 #63 Difficulties in administer Patr cia Quirino Costa, medicines to children with chronic Marina Garruti illnesses at home Medeiros, D bora Silva Gon alves, and Helena Luna Coelho 64 #64 The use of PILLGLIDE in children: Mamta Jagani, H l ne a pilot study Legay, Sejal Ranmal, Kuan Ooi, and Catherine Tuleu 65 #65 paediatricians' perspectives and Sejal Ranmal, Anne practices using solid oral dosage Cram, and Catherine forms for children Tuleu 66 #66 drug characteristics influence on Petkova Valentina children compliance 67 #67 Developing novel cerates as Joachim K ck @uni- substitutes for White Soft Paraffin Formulating Better Medicines for Children 2.


Related search queries